USPTO serial 99908104
LEGION 100
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with LEGION 100?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Fort Lauderdale, FL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jessica L. Rothstein
Jessica L. Rothstein Goodwin Procter LLP620 Eighth AvenueNew York, NY 10018United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical devices for the treatment of solid tumor cancers which cause partial intratumoral cell lysis and which deliver direct infusion of one or more Active Pharmaceutical Ingredients (APIs), whether biological or chemical agents or mixtures and formulations thereof into the tumor or to a localized region of the body at the site of partial intratumoral cell lysis; Medical apparatus, namely, devices which cause partial intratumoral cell lysis and which permit infusion and injection for locally targeted administration at the site of partial intratumoral lysis of one or more Active Pharmaceutical Ingredients (APIs), whether biological or chemical agents or mixtures and formulations thereof | ACTIVE | — |
| 042 | Providing a website featuring information in the field of clinical trials; conducting clinical trials of a system for the treatment of solid tumor cancers which causes partial intratumoral cell lysis and which delivers direct infusion of one or more Active Pharmaceutical Ingredients (APIs), whether biological or chemical agents or mixtures and formulations thereof into the tumor or to a localized region of the body at the site of partial intratumoral cell lysis | ACTIVE | — |
| 044 | Providing a website featuring information in the field of health and medicine; conducting clinical trials of a system for the treatment of solid tumor cancers which causes partial intratumoral cell lysis and which delivers direct infusion of one or more Active Pharmaceutical Ingredients (APIs), whether biological or chemical agents or mixtures and formulations thereof into the tumor or to a localized region of the body at the site of partial intratumoral cell lysis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 26, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 26, 2026 | NWAP | NEW APPLICATION ENTERED | — |